Sanjivani Paranteral Limited (BSE: 531569)
Health Care · Pharmaceuticals · IN
Rs180.25
+9.18% today · -16.1% 1Y
Sanjivani Paranteral Limited (BSE: 531569) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $22.88M.
Over the last twelve months the share price has lost 16.1%, trading between 126.00 and 244.00.
Tweenvest scores Sanjivani Paranteral Limited across four factors: quality 66/100, value 52/100, growth 91/100. Its strongest factor is growth.
531569 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $22.88M
- Revenue (TTM)
- $7.89M
- P/E
- 29.77
- EPS
- 6.05
- Dividend yield
- —
- Beta (5Y)
- -0.01
- 52-week high
- Rs244.00
- 52-week low
- Rs126.00
- Avg volume (3M)
- —
- Shares outstanding
- 12.28M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Emyria LimitedASX: EMD | $23.64M | AU$0.04 | -6.67% |
| Kontafarma China Holdings LimitedSEHK: 1312 | $23.50M | HK$0.03 | +3.13% |
| Tdspharm Co., Ltd.KOSDAQ: A464280 | $22.99M | ₩5,590.00 | +3.71% |
| BCWORLD PHARM. Co., Ltd.KOSDAQ: A200780 | $22.96M | ₩3,020.00 | -0.98% |
| Optimi Health Corp.CNSX: OPTI | $22.87M | CA$5.70 | -10.94% |
| Provectus Biopharmaceuticals, Inc.OTCPK: PVCT | $22.23M | $0.05 | -2.76% |
| Sat Kartar Life LimitedNSEI: SATKARTAR | $22.22M | Rs136.60 | -25.80% |
| Neurothera Labs Inc.TSXV: NTLX | $22.17M | CA$2.30 | -47.73% |
Figures last refreshed Oct 11, 2026.